WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? This action concerns the Defendants' fraudulent scheme to depress the value of Sina ordinary shares to avoid paying a fair price to Sina's shareholders in connection with a take-private acquisition by a buyer group controlled by Sina's Chief Executive Officer (the "Merger"). Defendants executed this scheme by misrepresenting and/or omitting material information within and from Sina's proxy materials in connection with the Merger that were necessary for sh ...

Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle Peyton Pomerantz LLP [email protected] 646-581-9980 ext. 7980 SOURCE Pomerantz LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? , /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Informatica Inc. ("Informatica" or the "Company") (NYSE: INFA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whethe ...

公司临床研发进展 - 公司于2025年9月28日公布其sonelokimab的3期VELA临床试验结果令人失望 [1] - 其中一项试验未能达到主要终点 另一项试验仅显示出相较于安慰剂的轻微改善 [1] 公司股价表现 - 在临床结果公布后 公司股价于2025年9月29日暴跌每股55.75美元 跌幅达89.93% 收盘报每股6.24美元 [1] 公司面临的调查 - Pomerantz LLP正就公司及其部分高管和/或董事是否涉及证券欺诈或其他非法商业行为展开调查 [1]

[Click here for information about joining the class action] The investigation concerns whether Organogenesis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On September 25, 2025, Organogenesis issued a press release disclosing that a second phase 3 trial of its cryopreserved amniotic suspension allograft ReNu missed its primary endpoint, having failed to achieve a significantly significant change in pain reduction. The Company said it wou ...

集体诉讼事件 - Pomerantz LLP宣布对Fortinet公司提起集体诉讼 涉及证券欺诈或其他非法商业行为的指控 [1][2] - 诉讼的提起日期截止至2025年11月21日 在此期间购买或收购公司证券的投资者可申请成为首席原告 [2] 公司披露与市场反应 - 公司在2025年8月6日的季度财报电话会中披露 其核心产品FortiGate防火墙的2026年升级周期在2025年第二季度末已完成约40%至50% [2] - 公司承认难以预测需要升级的FortiGate设备总数 并指出客户因前几年购买而拥有过剩的防火墙容量 导致升级需求不足 [2] - 公司透露此次硬件更新仅占其业务的很小百分比 因此未产生显著的业务影响 [2] - 此消息导致公司股价在2025年8月7日下跌每股21.28美元 跌幅达22.03% 收盘报每股75.30美元 [3] 法律事务所背景 - Pomerantz LLP在纽约、芝加哥、洛杉矶、伦敦、巴黎和特拉维夫设有办事处 在公司、证券和反垄断集体诉讼领域被视为领先律所之一 [4] - 该律所由已故的Abraham L Pomerantz创立 其在证券集体诉讼领域拥有超过85年历史 并为集体成员追回过多笔数百万美元的赔偿 [4]

[Click here for information about joining the class action] If you are an investor who purchased or otherwise acquired Cepton securities during the Class Period, you have until December 8, 2025, to ask the Court to appoint you as Lead Plaintiff for the class.A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e- mail are encouraged to include the ...

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/ ...

诉讼核心信息 - 律师事务所Berger Montague PC代表在2025年2月26日至2025年8月8日期间购买或收购C3ai股票的投资者提起集体诉讼 [1] - 寻求被任命为首席原告代表的投资者需在2025年10月21日前行动 [1] 诉讼指控内容 - 指控C3ai通过描绘过于乐观的增长轨迹误导投资者，同时隐瞒关键不利事实 [2] - 被指控隐瞒的事实包括其首席执行官健康状况对交易执行和公司运营绩效的重大影响 [2] - 2025年8月8日，公司发布了低于预期的2026财年第一季度初步财务业绩，并下调了收入预期，理由包括首席执行官健康问题和内部重组 [2] - 消息公布后，公司股价在单日交易中从每股2213美元大幅下跌至每股1647美元，跌幅超过25% [2]

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Palantir Technologies Inc. ("Palantir†or the "Company†) (NASDAQ: PLTR) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PALANTIR TECHNOLOGIES INC. (PLTR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Ha. ...

SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of KinderCare Learning Companies, Inc. (NYSE: KLC) common stock in or traceable to KinderCare’s October 2024 initial public offering (the “IPO”), have until Tuesday, October 14, 2025 to seek appointment as lead plaintiff of the KinderCare class action lawsuit. Captioned Gollapalli v. KinderCare Learning Companies, Inc., No. 25-cv-01424 (D. Or.), the KinderCare class action lawsuit charges KinderCare and c ...